S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
SHOCKING Crypto Leak… (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
How Biden has already won 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
SHOCKING Crypto Leak… (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
How Biden has already won 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
SHOCKING Crypto Leak… (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
How Biden has already won 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
SHOCKING Crypto Leak… (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
How Biden has already won 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial
NASDAQ:PRTO

Proteon Therapeutics (PRTO) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)
Free PRTO Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$2.66
▼
$2.89
50-Day Range
$0.84
▼
$25.13
52-Week Range
$0.22
▼
$3.94
Volume
241,473 shs
Average Volume
1.11 million shs
Market Capitalization
$60.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisCompetitorsSocial Media
PRTO stock logo

About Proteon Therapeutics Stock (NASDAQ:PRTO)

Proteon Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular disease. Its lead product candidate is vonapanitase, an investigational drug intended to enhance hemodialysis vascular access outcomes. The company develops vonapanitase, a recombinant human elastase, which has completed Phase II and Phase III clinical trials for patients with chronic kidney disease. It is also evaluating vonapanitase in a Phase I clinical trial in patients with peripheral artery disease. The company was founded in 2001 and is based in Waltham, Massachusetts.

PRTO Stock News Headlines

February 2, 2024 | macrumors.com
iPad Pro
November 5, 2023 | morningstar.com
Esperion Therapeutics Inc ESPR
April 19, 2024 | Crypto 101 Media (Ad)
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
September 20, 2023 | benzinga.com
The Latest Analyst Ratings for Revance Therapeutics
June 7, 2023 | finance.yahoo.com
ENLV - Enlivex Therapeutics Ltd.
May 25, 2023 | benzinga.com
Prelude Therapeutics Insider Trades Send a Signal
May 23, 2023 | benzinga.com
Global Protein Therapeutics Market Report 2023: Development of Plasma Derived Therapies Drives Growth
April 26, 2023 | benzinga.com
RAPT Therapeutics Announces FLX475 Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
April 19, 2024 | Crypto 101 Media (Ad)
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
February 22, 2023 | benzinga.com
Early Adopter of Remote Therapeutic Monitoring Achieves Significant Clinical and Financial Outcomes
January 22, 2023 | finance.yahoo.com
Cadrenal Therapeutics Announces Pricing of Initial Public Offering (IPO)
January 19, 2023 | wsj.com
Advanced Proteome Therapeutics Announces Its Proposed Plan of Arrangement
January 19, 2023 | marketwatch.com
Peripheral Arterial Disease (PAD) Therapeutics Market 2023 Size & Segmentation Analysis with Share, Trends till 2028 [ NEW REPORT ]
January 3, 2023 | benzinga.com
Business & Academia Join Forces To Study Magic Mushroom Therapy For IBS Patients
October 17, 2022 | msn.com
What 5 Analyst Ratings Have To Say About PTC Therapeutics
September 22, 2022 | msn.com
What 6 Analyst Ratings Have To Say About Revance Therapeutics
September 9, 2022 | finance.yahoo.com
Propella Therapeutics Announces Presentation of Phase 1/2 Data of PRL-02 for the Treatment of Advanced Prostate Cancer at ESMO Congress 2022
June 15, 2022 | finance.yahoo.com
ProthioneTM Capsules Reduced Time to COVID-19 Clinical Resolution and Decreased Viral Load in Phase II Clinical Trial
June 3, 2022 | thestreet.com
Bristol-Myers To Buy Turning Point Therapeutics In $4.1 Billion Oncology Deal
May 27, 2022 | bizjournals.com
Flagship Pioneering launches protein startup with $75M
See More Headlines
Receive PRTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteon Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/31/2019
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:PRTO
CUSIP
N/A
CIK
1359931
Web
www.proteontherapeutics.com
Phone
781-890-0102
Fax
N/A
Employees
17
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($1.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-20,730,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-118.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.98
Quick Ratio
5.98

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.06) per share
Price / Book
-45.83

Miscellaneous

Outstanding Shares
22,179,000
Free Float
N/A
Market Cap
$60.99 million
Optionable
Not Optionable
Beta
0.60
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Timothy P. Noyes (Age 57)
    Pres, CEO & Director
  • Mr. George A. Eldridge (Age 56)
    Sr. VP, CFO, Treasurer & Assistant Sec.
  • Dr. Steven Keith Burke (Age 58)
    Sr. VP & Chief Medical Officer
  • Mr. Matthew P. Kowalsky (Age 46)
    VP of Legal & Sec.
  • Mr. Bradley J. Hartman (Age 38)
    VP of People

Key Competitors

View All Competitors

PRTO Stock Analysis - Frequently Asked Questions

How were Proteon Therapeutics' earnings last quarter?

Proteon Therapeutics Inc (NASDAQ:PRTO) issued its quarterly earnings data on Thursday, October, 31st. The biopharmaceutical company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.01.

What other stocks do shareholders of Proteon Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Proteon Therapeutics investors own include SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE), Sierra Oncology (SRRA), Agile Therapeutics (AGRX), Biocept (BIOC), Gilead Sciences (GILD), ImmunoGen (IMGN), Inovio Pharmaceuticals (INO) and Novavax (NVAX).

This page (NASDAQ:PRTO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
Options trading has suddenly become more reliable.
Eagle Publishing
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends